Investment firm Gulf Capital pursues growth in Indian branch of top fertility company following sale of Middle East assets.
Gulf Capital, a UAE-based private equity firm, has announced its strategic focus on India's fertility market, retaining ownership of the ART Fertility Clinics’ India business after selling its Middle East operations. The company plans to pursue "aggressive growth" in India, reflecting high confidence in the market potential and operational success there.
The move comes after Gulf Capital invested $30 million in 2021 to expand ART Fertility Clinics into India. Since then, the chain has grown from a UAE-centric operation to a regional platform, comprising 15 clinics, with 11 located in India. This expansion has led to significant revenue and EBITDA growth, with profitability quadrupling over five years, achieved through regional expansion, operational improvements, infrastructure investment, and high IVF success rates.
The decision to retain and focus on the Indian business suggests Gulf Capital sees continued high growth potential driven by India’s increasing demand for fertility treatments and assisted reproduction services. The exact nature of the growth strategy has not been disclosed, but it is expected to involve further expansion and investment in the Indian operations.
Meanwhile, in other news, Blackstone is reportedly expanding its infrastructure team as part of its investment push into the sector. The exact nature of this investment push is not specified.
Elsewhere, KKR's second-quarter profit has risen due to growth in fee income. Evergreen Power, Vertis InvIT, NARCL, and Krafton are also currently in the news, but the nature of their investments is not specified.
Karim El Solh, the CEO of Gulf Capital, predicts record exits and investor returns next year. This prediction, along with Gulf Capital's decision to focus on the Indian fertility sector, indicates a positive outlook for the firm's investment strategies.
In conclusion, Gulf Capital views the Indian fertility sector as a key area for accelerated expansion, leveraging ART Fertility’s established presence and reputation to capitalize on robust market dynamics. The deal for the majority stake in the fertility chain, estimated to be between $400 million and $450 million, occurred last week, marking a significant step in Gulf Capital's investment strategy.
- Gulf Capital's plan for aggressive growth in India's fertility market is underpinned by a $30 million investment made in 2021, which led to the growth of ART Fertility Clinics from a UAE-centric operation to a regional platform with 15 clinics, 11 of which are in India.
- The decision by Gulf Capital to retain and focus on the Indian business follows increased profitability over five years, achieved through regional expansion, operational improvements, infrastructure investment, and high IVF success rates, suggesting the firm sees continued high growth potential in the Indian market.
